@phdthesis{107cc4b64ea0423cbb4a58c6012d62cf,
title = "Decoding Genetic Enigmas in Sarcoma",
abstract = "Sarcomas represent a broad and heterogenous group of rare tumors. For some subtypes, there arepathognomonic genetic alterations available, while for others such alterations remain to be identified.Especially in entities that harbor large numbers of complex genetic changes, much still remains to beunderstood. One such entity is osteosarcoma, the most common primary bone tumor. Although primarilyaffecting children and adolescents, this tumor typically presents a chaotic genome. In Papers I-III, wepresent different genetic mutational mechanisms that distinguish osteosarcoma sub-entities with differentbiology and tumor behavior. Namely, we present a recurrent mechanism involving the promoter regionof the TP53 tumor suppressor gene in a subset of conventional osteosarcomas. We demonstrate thatstructural variants abrogate TP53 expression but also relocate its promoter region. By responding toongoing DNA damage, it in turn leads to upregulation of known or putative oncogenes erroneouslytranslocated into its vicinity. Additionally, we subdivide 12q-amplified osteosarcomas into four distinctgroups and show that recurrent promoter swapping events involving the FRS2 and PLEKHA5 regulatoryregions occur in many high-grade and dedifferentiated osteosarcomas with CDK4 and MDM2amplification. Moreover, we found that osteosarcomas with relatively few chromosomal alterations oradult onset are genetically heterogenous. Finally, in the last part of the thesis (Papers III-IV), weintroduced new bioinformatics tools: (i) NAFuse to detect gene fusions; (ii) the genomic complexity score(GCS) to analyze the complexity genome-wide; and (iii) SarcDBase, a tool that integrates genomic andtranscriptomic data with existing information. Collectively, this thesis has advanced our understanding ofthe role played by specific mutations in the development and progression of osteosarcoma and hasintroduced new bioinformatics tools that facilitate the analysis and interpretation of highly complexgenetic information.",
author = "Valeria Difilippo",
note = "Defence details Date: 2024-05-16 Time: 09:00 Place: Belfragesalen, BMC D15, Klinikgatan 32 i Lund External reviewer(s) Name: Pillay, Nischalan Title: Associate professor Affiliation: University College London Cancer Institute, London, UK",
year = "2024",
language = "English",
isbn = "978-91-8021-553-4",
series = "Lund University, Faculty of Medicine Doctoral Dissertation Series",
publisher = "Lund University, Faculty of Medicine",
number = "2024:60",
type = "Doctoral Thesis (compilation)",
school = "Department of Laboratory Medicine",
}